SCHEMBL21148490

SCHEMBL21148490

c1cc(-c2nc(-c3ccc(-c4cc5ccccc5c5ccccc45)cc3)nc(-c3ccc4ccccc4c3)n2)cc(-c2cccc3sc4ccccc4c23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 8/20 0.37
S1PR4 O95977 6/20 0.37
CYP11B1 P15538 1/20 0.36
ALDH1A1 P00352 3/20 0.34
HSD17B10 Q99714 2/20 0.34
HPGD P15428 2/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP1 P29466 1/20 0.34
HIF1A Q16665 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GPR84 Q9NQS5 1/20 0.33
LIMK1 P53667 1/20 0.33
ALOX5 P09917 1/20 0.33
CYP1A2 P05177 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
TP53 P04637 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21149134 0.94 S1PR5 (0.38) S1PR5S1PR4CYP11B1ALDH1A1HSD17B10
SCHEMBL21148499 0.93 S1PR5 (0.36) S1PR5S1PR4CYP11B1ALDH1A1HSD17B10
SCHEMBL21148587 0.91 S1PR5 (0.40) S1PR5S1PR4ALDH1A1HSD17B10HPGD
SCHEMBL21148190 0.91 S1PR5 (0.42) S1PR5S1PR4ALDH1A1HSD17B10HPGD
SCHEMBL24266744 0.91 S1PR5 (0.41) S1PR5S1PR4ALDH1A1HSD17B10HPGD
SCHEMBL27455376 0.91 S1PR5 (0.43) S1PR5S1PR4ALDH1A1HSD17B10HPGD
SCHEMBL24266399 0.91 S1PR5 (0.40) S1PR5S1PR4ALDH1A1HSD17B10HPGD
SCHEMBL21149245 0.91 S1PR5 (0.40) S1PR5S1PR4ALDH1A1HSD17B10HPGD
SCHEMBL21148188 0.90 S1PR5 (0.41) S1PR5S1PR4CYP11B1ALDH1A1HSD17B10
SCHEMBL21148579 0.90 S1PR5 (0.39) S1PR5S1PR4CYP11B1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 S1PR5 3651/4885S1PR4 3107/4885CYP11B1 1932/4885
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 S1PR5 3651/4885S1PR4 3107/4885CYP11B1 1932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.